Breast cancer could be detected up to five years before there are any clinical signs of it, using a blood test that identifies the body’s immune response to substances produced by tumour cells, according to new research presented at the 2019 NCRI Cancer Conference today (Sunday).
Cancer cells produce proteins called antigens that trigger the body to make antibodies against them – autoantibodies. Researchers at the University of Nottingham (UK) have found that these tumour-associated antigens (TAAs) are good indicators of cancer, and now they have developed panels of TAAs that are known already to be associated with breast cancer to detect whether or not there are autoantibodies against them in blood samples taken from patients.
In a pilot study the researchers, who are part of the Centre of Excellence for Autoimmunity in Cancer (CEAC) group at the School of Medicine, University of Nottingham, took blood samples from 90 breast cancer patients at the time they were diagnosed with breast cancer and matched them with samples taken from 90 patients without breast cancer (the control group).
They used screening technology (protein microarray) that allowed them to screen the blood samples rapidly for the presence of autoantibodies against 40 TAAs associated with breast cancer, and also 27 TAAs that were not known to be linked with the disease.
Presenting the research at the NCRI Conference, Ms Daniyah Alfattani, a PhD student in the group, said: “The results of our study showed that breast cancer does induce autoantibodies against panels of specific tumour-associated antigens. We were able to detect cancer with reasonable accuracy by identifying these autoantibodies in the blood.”
The researchers identified three panels of TAAs against which to test for autoantibodies. The accuracy of the test improved in the panels that contained more TAAs. The panel of five TAAs correctly detected breast cancer in 29% of the samples from the cancer patients and correctly identified 84% of the control samples as being cancer-free. The panel of seven TAAs correctly identified cancer in 35% of cancer samples and no cancer in 79% of control samples. The panel of nine antigens correctly identified cancer in 37% of cancer samples and no cancer in 79% of the controls.
“We need to develop and further validate this test,” said Ms Alfattani. “However, these results are encouraging and indicate that it’s possible to detect a signal for early breast cancer. Once we have improved the accuracy of the test, then it opens the possibility of using a simple blood test to improve early detection of the disease.”
The researchers are now testing samples from 800 patients against a panel of nine TAAs, and they expect the accuracy of the test to improve with these larger numbers.
“A blood test for early breast cancer detection would be cost effective, which would be of particular value in low and middle income countries. It would also be an easier screening method to implement compared to current methods, such as mammography,” said Ms Alfattani.
The researchers estimate that, with a fully-funded development programme, the test might become available in the clinic in about four to five years.
A similar test for lung cancer is currently being tested in a randomised controlled trial in Scotland, involving 12,000 people at high risk of developing lung cancer because they smoke. They have been randomised to have (or not) an autoantibody blood test called ELISA (Early CDT-Lung). Participants who test positive for the autoantibodies are then followed up with a CT scan every two years in order to detect lung cancer in its early stages when it is easier to treat.
The CEAC group is also working on similar tests for pancreatic, colorectal and liver cancers. Solid tumours like these, as well as lung and breast cancer, represent around 70% of all cancers.
“A blood test capable of detecting any of these cancers at an early stage is the over-riding objective of our work,” concluded Ms Alfattani.
Dr Iain Frame, CEO of NCRI said: “Early diagnosis using simple, non-invasive ways of detecting the first signs of cancer is a key strategic priority for NCRI and something we’d all like to see working in practice. The results from this pilot study for a blood test to detect early breast cancer are promising and build on this research group’s expertise in other cancers, such as lung cancer. It’s obviously early days but we look forward to seeing the results from the larger group of patients that are now being investigated.”
The Latest on: Breast cancer
via Google News
The Latest on: Breast cancer
- Breast Cancer Survivor Chhavi Mittal Shares Health Update. "30 More Days And I'll Be A Free Bird," She Writeson June 16, 2022 at 3:10 am
Ek Chutki Aasma actress Chhavi Mittal shared a new post on her Instagram entry that reflects her current mood. The actress, who was diagnosed with breast cancer earlier this year, shared an update on ...
- Top in hem/onc: Financial management tips; breast cancer treatment strategieson June 16, 2022 at 2:04 am
In the latest installment of Residency to Retirement, wealth management experts discussed how physicians can safeguard their bond investments. It was the top story in hematology/oncology last week.
- Breast Cancer: What women must knowon June 16, 2022 at 1:59 am
Actor Mahima Chaudhry’s battle with breast cancer has brought to light, yet again, the need for awareness and timely treatment. We speak to experts about the signs to watch out for ...
- Breast Cancer Society of Canada Grants $250,000 To Precision Oncology Research at Dalhousie Universityon June 15, 2022 at 7:34 am
The Breast Cancer Society of Canada (BCSC) today announced $250,000 in funding to the Department of Biochemistry and Molecular Biology, Faculty of Medicine at Dalhousie University, for a research ...
- 3D mammography may reduce the chance of advanced breast cancer diagnosis for some womenon June 14, 2022 at 10:28 pm
For many women, breast cancer screening with a three-dimensional imaging technique called digital breast tomosynthesis (DBT) may not offer advantages over digital mammography, but for some it may ...
- Healthy plant-based diet may cut breast cancer riskon June 14, 2022 at 11:01 am
Adherence to a healthful plant-based food diet is associated with reduced risk of breast cancer for postmenopausal women, according to a study presented during Nutrition 2022, the annual meeting of ...
- Breast Cancer Survivor Urges Critical Screenings: 'It Will Save Your Life'on June 14, 2022 at 7:29 am
While it can be easy to put off routine breast cancer screenings, Aimée Stahel says you can’t. If she had, it may have cost her life.
- Helpers indeed: immune cells combat breast canceron June 14, 2022 at 2:56 am
A novel immunotherapy for treating breast cancer has been designed in mice and could be applicable to the treatment of other forms of cancer in the future. A team of researchers led by Shawn Demehri ...
- Diabetes Threatens Long-Term Survival in Metastatic Breast Canceron June 13, 2022 at 12:07 pm
For metastatic breast cancer patients, diabetes appeared to hurt outcomes only among long-term survivors, researchers reported. In a retrospective study of people with metastatic breast cancer, ...
- Metastatic breast cancer panel discussion set for Thursday in Orangeon June 13, 2022 at 9:15 am
A panel discussion on metastatic breast cancer set for Thursday will focus on “Life Support: Clinical Trials for Metastatic Breast Cancer” and how patients with health and racial disparities can gain ...
via Bing News